Barely Significant
← all excerpts

Preclinical Screening Platform Identifies Azatadine-Dimaleate as a Potent Repurposed Therapeutic Against SARS-CoV-2 Infection.

J Med Virol · 2025 · PMC12631721 · PMID 41263140

Europe PMCDOI
3
hedged sentences
0.0700
closest p · 1.4× alpha
0.0700
boldest claim

The sentences

a trend towards significancep = 0.07so close (0.05 < p ≤ 0.1)
Further analysis at day 3 postinfection revealed that the combination therapy showed a trend towards significance ( p = 0.07) compared to vehicle controls.

also in 987 other papers

showed a trendp = 0.07so close (0.05 < p ≤ 0.1)
Further analysis at day 3 postinfection revealed that the combination therapy showed a trend towards significance ( p = 0.07) compared to vehicle controls.

also in 24,539 other papers

did not reach statistical significanceno p-value reported
Animals treated with combination therapy demonstrated similar weight preservation (mean 4% reduction), although this did not reach statistical significance in the final timepoint analysis.

also in 57,071 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.